Bruker Q2 Revenues Fall 6 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Bruker reported after the close of the market Tuesday that its second quarter revenues were down 6 percent year over year, and down more than 9 percent excluding the effect of acquisitions.

For the three months ended June 30, Billerica, Massachusetts-based Bruker reported revenues of $371.7 million, compared to $396.0 million in Q2 2015.

Changes in foreign exchange rates did not impact the company's revenues. The results came in below the average Wall Street estimate of $410.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.